Autor: "Yiorkas, AM" - OpacWWW

Skocz do pozycji: 1.

Tytuł:: Mendelian randomisation analyses of UK Biobank and published data suggest that increased adiposity lowers risk of breast and prostate cancer.
Autorzy:: Amin HA; Department of Life Sciences, College of Health, Medical and Life Sciences, Brunel University London, Kingston Lane, Uxbridge, UB8 3PH, Middlesex, UK.
Kaewsri P; Department of Life Sciences, College of Health, Medical and Life Sciences, Brunel University London, Kingston Lane, Uxbridge, UB8 3PH, Middlesex, UK.
Yiorkas AM; Department of Life Sciences, College of Health, Medical and Life Sciences, Brunel University London, Kingston Lane, Uxbridge, UB8 3PH, Middlesex, UK.
Cooke H; Department of Life Sciences, College of Health, Medical and Life Sciences, Brunel University London, Kingston Lane, Uxbridge, UB8 3PH, Middlesex, UK.
Blakemore AI; Department of Life Sciences, College of Health, Medical and Life Sciences, Brunel University London, Kingston Lane, Uxbridge, UB8 3PH, Middlesex, UK.
Drenos F; Department of Life Sciences, College of Health, Medical and Life Sciences, Brunel University London, Kingston Lane, Uxbridge, UB8 3PH, Middlesex, UK. .; Pokaż więcej
Źródło:: Scientific reports [Sci Rep] 2022 Jan 18; Vol. 12 (1), pp. 909. Date of Electronic Publication: 2022 Jan 18.
Typ publikacji:: Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:: Breast Neoplasms*

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 2.

Tytuł:: Relationship between BMI and emotion-handling capacity in an adult Finnish population: The Northern Finland Birth Cohort 1966.
Autorzy:: Ramzi NH; Section of Investigative Medicine, Division of Diabetes, Endocrinology, and Metabolism, Faculty of Medicine, Imperial College London, London, United Kingdom.; Department of Life Sciences, College of Health and Life Sciences, Brunel University London, London, United Kingdom.
Yiorkas AM; Section of Investigative Medicine, Division of Diabetes, Endocrinology, and Metabolism, Faculty of Medicine, Imperial College London, London, United Kingdom.; Department of Life Sciences, College of Health and Life Sciences, Brunel University London, London, United Kingdom.
Sebert S; Center for Life Course Health Research, Faculty of Medicine, University of Oulu, Oulu, Finland.; Biocenter Oulu, University of Oulu, Oulu, Finland.
Keinänen-Kiukaanniemi S; Center for Life Course Health Research, Faculty of Medicine, University of Oulu, Oulu, Finland.; Unit of Primary Health Care and Medical Research Center, Oulu University Hospital, Oulu, Finland.
Ala-Mursula L; Center for Life Course Health Research, Faculty of Medicine, University of Oulu, Oulu, Finland.
Svento R; Center for Life Course Health Research, Faculty of Medicine, University of Oulu, Oulu, Finland.; Unit of Primary Health Care and Medical Research Center, Oulu University Hospital, Oulu, Finland.
Jokelainen J; Center for Life Course Health Research, Faculty of Medicine, University of Oulu, Oulu, Finland.; Unit of Primary Health Care and Medical Research Center, Oulu University Hospital, Oulu, Finland.
Veijola J; Medical Research Center Oulu, Oulu University Hospital and University of Oulu, Oulu, Finland.
Auvinen J; Center for Life Course Health Research, Faculty of Medicine, University of Oulu, Oulu, Finland.; Unit of Primary Health Care and Medical Research Center, Oulu University Hospital, Oulu, Finland.
Miettunen J; Center for Life Course Health Research, Faculty of Medicine, University of Oulu, Oulu, Finland.; Medical Research Center Oulu, Oulu University Hospital and University of Oulu, Oulu, Finland.; Department of Psychiatry, Research Unit of Clinical Neuroscience, Oulu University Hospital and University of Oulu, Oulu, Finland.
Dovey TM; Department of Life Sciences, College of Health and Life Sciences, Brunel University London, London, United Kingdom.
Järvelin MR; Department of Life Sciences, College of Health and Life Sciences, Brunel University London, London, United Kingdom.; Center for Life Course Health Research, Faculty of Medicine, University of Oulu, Oulu, Finland.; Biocenter Oulu, University of Oulu, Oulu, Finland.; Unit of Primary Health Care and Medical Research Center, Oulu University Hospital, Oulu, Finland.; Department of Epidemiology and Biostatistics, MRC-PHE Centre for Environment & Health, School of Public Health, Imperial College London, London, United Kingdom.
Blakemore AIF; Section of Investigative Medicine, Division of Diabetes, Endocrinology, and Metabolism, Faculty of Medicine, Imperial College London, London, United Kingdom.; Department of Life Sciences, College of Health and Life Sciences, Brunel University London, London, United Kingdom.; Pokaż więcej
Źródło:: PloS one [PLoS One] 2018 Sep 26; Vol. 13 (9), pp. e0203660. Date of Electronic Publication: 2018 Sep 26 (Print Publication: 2018).
Typ publikacji:: Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:: Affective Symptoms/*complications
Obesity/*complications
Adult ; Body Mass Index ; Female ; Finland ; Humans ; Longitudinal Studies ; Male ; Middle Aged ; Psychiatric Status Rating Scales

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 3.

Tytuł:: Truncating Homozygous Mutation of Carboxypeptidase E (CPE) in a Morbidly Obese Female with Type 2 Diabetes Mellitus, Intellectual Disability and Hypogonadotrophic Hypogonadism.
Autorzy:: Alsters SI; Section of Investigative Medicine, Division of Diabetes, Endocrinology, and Metabolism, Department of Medicine, Imperial College London, London, United Kingdom.
Goldstone AP; Imperial Centre for Endocrinology, Imperial College Healthcare NHS Trust, Hammersmith Hospital, London, United Kingdom; Centre for Neuropsychopharmacology and Computational, Cognitive and Clinical Neuroimaging Laboratory, Division of Brain Sciences, Department of Medicine, Imperial College London, Hammersmith Hospital, London, United Kingdom; Metabolic and Molecular Imaging Group, MRC Clinical Sciences Centre, Imperial College London, Hammersmith Hospital, London, United Kingdom.
Buxton JL; Section of Investigative Medicine, Division of Diabetes, Endocrinology, and Metabolism, Department of Medicine, Imperial College London, London, United Kingdom; Centre for Cardiovascular Genetics, UCL Institute of Cardiovascular Science, London, United Kingdom.
Zekavati A; NIHR Imperial BRC Genomics Facility, Faculty of Medicine, Imperial College London, London, United Kingdom.
Sosinsky A; NIHR Imperial BRC Genomics Facility, Faculty of Medicine, Imperial College London, London, United Kingdom.
Yiorkas AM; Section of Investigative Medicine, Division of Diabetes, Endocrinology, and Metabolism, Department of Medicine, Imperial College London, London, United Kingdom.
Holder S; NW Thames Regional Genetics Service, Kennedy Galton Centre, North West London Hospitals NHS Trust, Northwick Park Hospital, Harrow, United Kingdom.
Klaber RE; Department of Paediatrics, Imperial College Healthcare NHS Trust, St Mary's Hospital, London, United Kingdom.
Bridges N; Department of Paediatric Endocrinology, Chelsea and Westminster Hospital, London, United Kingdom.
van Haelst MM; Department of Medical Genetics, Wilhelmina Children's Hospital, University Medical Center Utrecht, Utrecht, The Netherlands.
le Roux CW; Section of Investigative Medicine, Division of Diabetes, Endocrinology, and Metabolism, Department of Medicine, Imperial College London, London, United Kingdom; Diabetes Complications Research Centre, Conway Institute, School of Medicine and Medical Science, University College Dublin, Dublin, Ireland.
Walley AJ; Department of Epidemiology and Biostatistics, School of Public Health, Imperial College London, London, United Kingdom.
Walters RG; Clinical Trial Service Unit and Epidemiological Studies Unit (CTSU), Nuffield Department of Population Health, University of Oxford, Oxford, United Kingdom.
Mueller M; NIHR Imperial BRC Genomics Facility, Faculty of Medicine, Imperial College London, London, United Kingdom.
Blakemore AI; Section of Investigative Medicine, Division of Diabetes, Endocrinology, and Metabolism, Department of Medicine, Imperial College London, London, United Kingdom.; Pokaż więcej
Źródło:: PloS one [PLoS One] 2015 Jun 29; Vol. 10 (6), pp. e0131417. Date of Electronic Publication: 2015 Jun 29 (Print Publication: 2015).
Typ publikacji:: Case Reports; Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:: Carboxypeptidase H/*genetics
Diabetes Mellitus, Type 2/*complications
Intellectual Disability/*complications
Klinefelter Syndrome/*complications
Mutation/*genetics
Obesity, Morbid/*complications
Obesity, Morbid/*genetics
Carboxypeptidase H/metabolism ; DNA Mutational Analysis ; Diabetes Mellitus, Type 2/enzymology ; Diabetes Mellitus, Type 2/genetics ; Exome/genetics ; Female ; Gene Expression Regulation, Enzymologic ; Homozygote ; Humans ; Intellectual Disability/genetics ; Klinefelter Syndrome/enzymology ; Klinefelter Syndrome/genetics ; Male ; Obesity, Morbid/enzymology ; Pedigree ; RNA, Messenger/genetics ; RNA, Messenger/metabolism ; Young Adult

Czasopismo naukowe

na półce

Pełny tekst Szczegóły

Informacja

Wyszukujesz frazę ""Yiorkas, AM"" wg kryterium: Autor

Źródło danych

Ogranicz do:

Ogranicz do bazy

Typ dokumentu

Temat

Wydawca

Publikacja

Język